SB 1453 revises Missouri law governing telemedicine and telehealth by tightening the requirements for establishing a valid physician-patient relationship before treatment or prescribing can occur remotely. The bill repeals and reenacts sections 191.1146 and 334.108 to specify that a relationship may be formed through an in-person evaluation and physical examination, consultation with another physician who already has a relationship with the patient, or a telemedicine encounter only when the standard of care does not require an in-person visit and the encounter follows evidence-based telemedicine practice guidelines.
The bill also requires that, before treatment or prescriptions are provided, the physician must evaluate the patient, review relevant medical history, and perform an examination sufficient for diagnosis and treatment. If a questionnaire is used by internet or telephone, it must be reviewed by a treating health care professional and contain enough information to function like an in-person medical evaluation; otherwise it is not an acceptable basis for treatment. Providers using such questionnaires must also be employed by or contracted with a Missouri-licensed health care business and must send a written report to the patient’s primary care provider within 14 days, if one is identified.
For prescribing, the bill reinforces that drugs, controlled substances, and other treatments may not be prescribed solely on the basis of a telemedicine or internet evaluation unless a valid ongoing physician-patient relationship already exists. It preserves exceptions for certain care settings and arrangements, including hospitals, hospice, home health, collaborative practice agreements, physician assistants, assistant physicians, on-call or cross-coverage situations, and consultation with another physician supervising ongoing care. It also requires medical records for telemedicine-prescribed treatment to be maintained in compliance with HIPAA and available for continuity of care.
The bill’s impact would be to narrow and clarify when remote care can substitute for in-person evaluation, while preserving telemedicine as a lawful delivery method under defined standards. It would affect physicians, advanced practice registered nurses, physician assistants, assistant physicians, telehealth companies, and patients seeking remote prescriptions or treatment, especially where online questionnaires or telephone-based evaluations are used.
The overall sentiment reflected by the bill text is cautious and regulatory rather than expansive: it appears aimed at preventing treatment based on minimal remote screening while still allowing telemedicine within professional standards. No committee transcripts or votes were provided, so there is no recorded public debate in the supplied materials. The main point of contention implied by the language is the balance between access to telehealth and concerns about patient safety, adequate diagnosis, and limits on prescribing without an in-person exam.
SB 1453 would amend Missouri’s telemedicine statutes by repealing and reenacting sections 191.1146 and 334.108, thereby tightening the legal standards for remote diagnosis, treatment, and prescribing. It would require a valid physician-patient relationship to be established through an in-person exam, consultation with an existing treating physician, or a telemedicine encounter that meets the standard of care and evidence-based practice guidelines. It also adds requirements for questionnaire-based telemedicine, reporting to primary care providers, and HIPAA-compliant recordkeeping, while preserving exceptions for certain clinical settings and collaborative practice arrangements.
The bill’s tone is generally restrictive and precautionary, suggesting support for stronger oversight of telemedicine rather than expansion of remote-only care. Because no committee discussion or voting history was provided, there is no direct evidence of legislative support or opposition in the supplied record. Based on the text alone, the measure appears designed to reassure proponents of patient safety and diagnostic rigor, while likely drawing concern from telehealth advocates who may view the requirements as burdensome.
The central tension in SB 1453 is between access to convenient telehealth services and the need for a sufficiently robust medical evaluation before treatment or prescribing. Supporters of stricter standards would likely favor the bill’s limits on internet questionnaires, telephone-only evaluations, and prescribing without an established relationship, arguing these safeguards protect patients and improve continuity of care. Opponents or telehealth providers may object that the bill could reduce access, increase administrative burdens, and constrain innovative remote care models, particularly for patients in underserved or rural areas.